Pulse Biosciences Inc (PLSE) - Aggregate Business Assets

PLSE (Pulse Biosciences Inc) - company brandmark

This chart of financial quotes for the aggregate assets of Pulse Biosciences, Inc. (PLSE), which reach 117.91, demonstrates the foundation of a business creating nanosecond systems for dermatology and cardiology based on a long-term consumables sales model. Pulse Biosciences, Inc. (PLSE) is implementing innovative non-thermal tissue ablation, which is currently in the initial market penetration phase. The company's success is based on patent purity and regulatory approval of new methods of cellular impact.

PLSE (Pulse Corp) Company Total Assets history from 07/04/2022 to 10/29/2026

Financial and market metric breakdowns for Pulse Corp (PLSE)

- stock value and consensus price forecast:
Market Price pulsebiosciences.com|PLSE - Consensus Target
- market capitalization indicators:
Market Value Pulse Medical|PLSE - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share Pulse Biosciences|PLSE - Book Capitalization|Market-to-Book Ratio pulsebiosciences.com|PLSE - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Pulse Biosciences, Inc.|PLSE - Long-Term Debt to Capital|Short-Term Debt to Capital Pulse Medical|PLSE - Company Debts|Debts to Book Capitalization Ratio Pulse Medical|PLSE - Company Long-Term Debts|Short-Term Debt Pulse Biosciences|Quick Ratio pulsebiosciences.com
- net income and valuation multiples indicators:
PLSE - Net Income
Basic company analysis:pulsebiosciences.com PLSE
Manufactured products of Pulse Corp

Organic growth in non-thermal ablation technologies and partnerships with clinics define the resource base of Pulse Biosciences, Inc. (PLSE), excluding the impact of M&A transactions. The dynamics of the total capital and liabilities structure are reverse-calculated here via ROA, reflecting the full value of controlled assets, which allows investors to differentiate genuine business expansion from the temporary liquidity spikes typical of small-cap companies.

Direct competitors

Company Assets dexcom.com (DXCM)|Cumulative Company Assets PEN|NOVT (Novanta Inc) - Aggregate Business Assets|Company Total Assets HAE|INSP (Inspire Medical Systems Inc) - Aggregate Asset Value|Company Total Assets PRCT (PROCEPT BioRobotics)|conmed.com (CNMD) - Company Assets|INMD - Aggregate Company Assets|Aggregate Asset Value PMI (Picard Medical Corp)|SRDX: Company Total Assets|Senseonics Holdings, Inc. (SENS) - Company Total Assets|Aggregate Company Assets NeuroPace, Inc.|Tactile Systems Technology Inc. - Total Asset Value of Company|Company Total Assets SNWV|OM - Company Assets|Electromed - Cumulative Company Assets|Company Total Assets LENSAR Inc LNSR|RCEL: Cumulative Company Assets|Profound Medical Corp. - Aggregate Business Assets|BDMD: Company Total Assets|EDAP - Company Total Asset Base|APYX (Apyx Medical Corp) - Company Total Assets|Cumulative Company Assets IceCure Medical, Ltd. (ICCM)|Cumulative Company Assets LUNG (Pulmonx Corporation)|TELA (telabio.com) - Aggregate Asset Value|Aggregate Company Assets CytoSorbents Corporation CTSO|SRTS - Cumulative Company Assets|Zynex Inc - Company Total Assets|Company Assets electroCore, Inc.|RBOT: Company Total Assets|Total Business Assets IINN|ICU (SeaStar Medical) - Company Total Assets|IRIDEX Corp. (IRIX) - Company Total Asset Base|Company Total Assets INBS|Cumulative Company Assets beyondair.net XAIR|Company Total Assets PFSA (Profusa Inc)|Company Total Assets STRATA Skin Sciences Inc. SSKN|GCTK - Aggregate Company Assets|NAOV: Aggregate Company Assets|VERO (Venus Concept Corp) - Cumulative Company Assets|Nuwellis Corp - Aggregate Asset Value|AEMD (Aethlon Medical) - Company Total Assets|Company Assets TransEnterix ASXC|Aggregate Company Assets Avinger (AVGR)|BioSig Technologies (BSGM) - Company Balance Sheet Assets|Cutera, Inc - Cumulative Company Assets|Company Total Assets Know Labs Corporation KNW|Inari Medical, Inc. - Company Total Assets|Company Total Asset Base nevro.com NVRO|reshapelifesciences.com (RSLS) - Aggregate Company Assets|Total Asset Value of Company SILK (Silk Road Medical, Inc.)